August 25, 2010 - A new technique that combines advanced radiologic imaging with precise tumor localization to remove a cancer in its entirety and with minimal disturbance to surrounding organs is available.

As reported in the latest issue of the Journal of Surgical Radiology, surgeons and radiologists at the Mayo Clinic have collaborated on an approach that uses tiny radioactive seeds implanted at the time of diagnosis. Surgeons can then use a handheld radiation detector (gamma probe) to precisely locate these seeds at the time of surgery and thereby remove the cancer safely and effectively, virtually without damaging tissues and organs near the affected area.

“RSL (radioactive seed localization) is a safe, accurate, and effective technique,” according to Dr. James Jakub, the senior author of the study and a surgeon at Mayo Clinic. “RSL has the potential to be adapted to most lesions amenable to a percutaneous (under the skin) approach.”

This advance in technology can be applied to a wide variety of cancers. For example, metastatic melanoma deposits scattered throughout the body can be identified by imaging studies and seeds implanted via CT-guided or ultrasound-guided techniques. Surgeons can then precisely locate these tumor deposits and remove them without significantly disturbing nearby vital structures.

Radioactive seed localization is also a flexible technology. It can be completed at the same time that other imaging studies are done. Surgeons then have up to five days to identify these seeds and excise the tumor. The radiation dose from the seeds is so negligible that surgeons removing the tumor need no extra protective covering.

The early results of the study demonstrate complete destruction of the metastasized tissues with no mortality and only two minor postsurgical infections. The scheduling of the placement of the seed need not be done on the same day as the PET and/or CT scans are performed, thereby maximizing convenience to the patient without sacrificing clinical outcome.

Radioactive seed localization offers the potential to change the way complex tumors are treated, owing to its safety, convenience to the patient, relatively low dose of radiation administered and success in excising the entire affected tissue.

For more information: www.SurgRad.com.


Related Content

News | FDA

Dec. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT, has announced ...

Time December 04, 2025
arrow
News | Interventional Radiology

Nov. 12, 2025 — On Nov. 11, Huntsman Cancer Institute at the University of Utah (the U) opened its first specialized ...

Time November 13, 2025
arrow
News | Radiology Business

Nov. 12, 2025 — Siemens has announced plans to deconsolidate its remaining stake in Siemens Healthineers (currently ...

Time November 13, 2025
arrow
News | Radiopharmaceuticals and Tracers

Nov. 11, 2025 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released a position paper outlining ...

Time November 12, 2025
arrow
News | Prostate Cancer

Nov. 10, 2025 — Researchers at Wayne State University and the Barbara Ann Karmanos Cancer Institute have developed a ...

Time November 11, 2025
arrow
News | Lung Imaging

Nov. 3, 2025 — RevealDx, a leader in the characterization of lung nodules, has introduced MDR Certification of RevealAI ...

Time November 07, 2025
arrow
News | Artificial Intelligence

Nov. 6, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, recently announced that Volpara ...

Time November 07, 2025
arrow
News | Prostate Cancer

Sept. 30, 2025 – EDAP TMS's non-invasive, nonsurgical treatment option, Focal One Robotic HIFU, was featured on national ...

Time September 30, 2025
arrow
News | Radiation Therapy

Sept. 25, 2025 — GE HealthCare has announced updates to Intelligent Radiation Therapy (iRT), a new version of the ...

Time September 25, 2025
arrow
News | Proton Therapy

Sept. 15, 2025 — Mevion Medical Systems announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) ...

Time September 18, 2025
arrow
Subscribe Now